Literature DB >> 20703329

The use of divalent metal ions by type II topoisomerases.

Joseph E Deweese1, Neil Osheroff.   

Abstract

Type II topoisomerases are essential enzymes that regulate DNA under- and overwinding and remove knots and tangles from the genetic material. In order to carry out their critical physiological functions, these enzymes utilize a double-stranded DNA passage mechanism that requires them to generate a transient double-stranded break. Consequently, while necessary for cell survival, type II topoisomerases also have the capacity to fragment the genome. This feature of the prokaryotic and eukaryotic enzymes, respectively, is exploited to treat a variety of bacterial infections and cancers in humans. All type II topoisomerases require divalent metal ions for catalytic function. These metal ions function in two separate active sites and are necessary for the ATPase and DNA cleavage/ligation activities of the enzymes. ATPase activity is required for the strand passage process and utilizes the metal-dependent binding and hydrolysis of ATP to drive structural rearrangements in the protein. Both the DNA cleavage and ligation activities of type II topoisomerases require divalent metal ions and appear to utilize a novel variant of the canonical two-metal-ion phosphotransferase/hydrolase mechanism to facilitate these reactions. This article will focus primarily on eukaryotic type II topoisomerases and the roles of metal ions in the catalytic functions of these enzymes.

Entities:  

Keywords:  ATP hydrolysis; DNA cleavage; DNA ligation; Topoisomerase IIα; divalent cation; divalent metal ion; topoisomerase II poisons

Mesh:

Substances:

Year:  2010        PMID: 20703329      PMCID: PMC2918885          DOI: 10.1039/c003759a

Source DB:  PubMed          Journal:  Metallomics        ISSN: 1756-5901            Impact factor:   4.526


  144 in total

1.  Tying a molecular knot with optical tweezers.

Authors:  Y Arai; R Yasuda; K Akashi; Y Harada; H Miyata; K Kinosita; H Itoh
Journal:  Nature       Date:  1999-06-03       Impact factor: 49.962

2.  Base excision repair intermediates as topoisomerase II poisons.

Authors:  A M Wilstermann; N Osheroff
Journal:  J Biol Chem       Date:  2001-10-08       Impact factor: 5.157

3.  Structural similarities between topoisomerases that cleave one or both DNA strands.

Authors:  J M Berger; D Fass; J C Wang; S C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

Review 4.  Eukaryotic DNA topoisomerase II beta.

Authors:  C A Austin; K L Marsh
Journal:  Bioessays       Date:  1998-03       Impact factor: 4.345

Review 5.  Appendix. II: Alignment of primary sequences of DNA topoisomerases.

Authors:  P R Caron; J C Wang
Journal:  Adv Pharmacol       Date:  1994

6.  Isolation and characterization of the gene encoding Drosophila DNA topoisomerase II.

Authors:  J M Nolan; M P Lee; E Wyckoff; T S Hsieh
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

7.  Stabilization of the topoisomerase II-DNA cleavage complex by antineoplastic drugs: inhibition of enzyme-mediated DNA religation by 4'-(9-acridinylamino)methanesulfon-m-anisidide.

Authors:  M J Robinson; N Osheroff
Journal:  Biochemistry       Date:  1990-03-13       Impact factor: 3.162

8.  Use of divalent metal ions in the dna cleavage reaction of human type II topoisomerases.

Authors:  Joseph E Deweese; Amber M Burch; Alex B Burgin; Neil Osheroff
Journal:  Biochemistry       Date:  2009-03-10       Impact factor: 3.162

9.  Isolation of cDNA clones encoding the beta isozyme of human DNA topoisomerase II and localisation of the gene to chromosome 3p24.

Authors:  J R Jenkins; P Ayton; T Jones; S L Davies; D L Simmons; A L Harris; D Sheer; I D Hickson
Journal:  Nucleic Acids Res       Date:  1992-11-11       Impact factor: 16.971

10.  C-terminal regions of topoisomerase IIalpha and IIbeta determine isoform-specific functioning of the enzymes in vivo.

Authors:  René M Linka; Andrew C G Porter; Arsen Volkov; Christian Mielke; Fritz Boege; Morten O Christensen
Journal:  Nucleic Acids Res       Date:  2007-05-25       Impact factor: 16.971

View more
  24 in total

1.  Drug interactions with Bacillus anthracis topoisomerase IV: biochemical basis for quinolone action and resistance.

Authors:  Katie J Aldred; Sylvia A McPherson; Pengfei Wang; Robert J Kerns; David E Graves; Charles L Turnbough; Neil Osheroff
Journal:  Biochemistry       Date:  2011-12-16       Impact factor: 3.162

2.  Single-molecule Förster resonance energy transfer (FRET) analysis discloses the dynamics of the DNA-topoisomerase II (Top2) interaction in the presence of TOP2-targeting agents.

Authors:  Wan-Chen Huang; Chun-Ying Lee; Tao-Shih Hsieh
Journal:  J Biol Chem       Date:  2017-06-19       Impact factor: 5.157

3.  Selection of DNA Cleavage Sites by Topoisomerase II Results from Enzyme-Induced Flexibility of DNA.

Authors:  Yunsu Jang; Heyjin Son; Sang-Wook Lee; Wonseok Hwang; Seung-Ryoung Jung; Jo Ann W Byl; Neil Osheroff; Sanghwa Lee
Journal:  Cell Chem Biol       Date:  2019-01-31       Impact factor: 8.116

4.  Phytochemicals as Anticancer and Chemopreventive Topoisomerase II Poisons.

Authors:  Adam C Ketron; Neil Osheroff
Journal:  Phytochem Rev       Date:  2014-03-01       Impact factor: 5.374

5.  Novel xanthone-polyamine conjugates as catalytic inhibitors of human topoisomerase IIα.

Authors:  Elirosa Minniti; Jo Ann W Byl; Laura Riccardi; Claudia Sissi; Michela Rosini; Marco De Vivo; Anna Minarini; Neil Osheroff
Journal:  Bioorg Med Chem Lett       Date:  2017-09-08       Impact factor: 2.823

6.  Coupling the core of the anticancer drug etoposide to an oligonucleotide induces topoisomerase II-mediated cleavage at specific DNA sequences.

Authors:  Lorena Infante Lara; Sabine Fenner; Steven Ratcliffe; Albert Isidro-Llobet; Michael Hann; Ben Bax; Neil Osheroff
Journal:  Nucleic Acids Res       Date:  2018-03-16       Impact factor: 16.971

Review 7.  Iron chelators with topoisomerase-inhibitory activity and their anticancer applications.

Authors:  V Ashutosh Rao
Journal:  Antioxid Redox Signal       Date:  2012-10-26       Impact factor: 8.401

8.  Metal ion and inter-domain interactions as functional networks in E. coli topoisomerase I.

Authors:  Claudia Sissi; Bokun Cheng; Valentina Lombardo; Yuk-Ching Tse-Dinh; Manlio Palumbo
Journal:  Gene       Date:  2013-04-20       Impact factor: 3.688

9.  QnrS1 structure-activity relationships.

Authors:  María M Tavío; George A Jacoby; David C Hooper
Journal:  J Antimicrob Chemother       Date:  2014-04-11       Impact factor: 5.790

10.  Fluoroquinolone-gyrase-DNA complexes: two modes of drug binding.

Authors:  Arkady Mustaev; Muhammad Malik; Xilin Zhao; Natalia Kurepina; Gan Luan; Lisa M Oppegard; Hiroshi Hiasa; Kevin R Marks; Robert J Kerns; James M Berger; Karl Drlica
Journal:  J Biol Chem       Date:  2014-02-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.